Get notified when CATX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPerspective Therapeutics discloses preliminary Q1 2026 cash position in analyst presentation
Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read
Key Changes
-
medium
Company disclosed preliminary, unaudited cash and short-term investments as of March 31, 2026 in a presentation posted to its website. The independent auditor has not reviewed these figures.
Item 7.01 view on EDGAR → -
medium
Actual Q1 2026 results may differ from preliminary data due to ongoing quarter-end closing procedures, final adjustments, and other developments arising before financial results are finalized.
Item 7.01 view on EDGAR → -
low
The 8-K filing serves to make the analyst presentation publicly available; no other material business events were disclosed.
Item 7.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade CATX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify